Literature DB >> 19690403

Small airway remodeling in idiopathic interstitial pneumonias: a pathological study.

George Castro Figueira de Mello1, Carlos Roberto Ribeiro Carvalho, Ronaldo Adib Kairalla, Paulo Hilário Nascimento Saldiva, Sandra Fernezlian, Luiz Fernando Ferraz Silva, Marisa Dolhnikoff, Thais Mauad.   

Abstract

BACKGROUND: Few studies have addressed small airway (SA) histopathological changes and their possible role in the remodeling process in idiopathic interstitial pneumonias.
OBJECTIVES: To study morphological, morphometrical and immunohistochemical features of SA in idiopathic pulmonary fibrosis (usual interstitial pneumonia, UIP) and nonspecific interstitial pneumonia (NSIP).
METHODS: We analyzed SA pathology in lung biopsies from 29 patients with UIP and 8 with NSIP. Biopsies were compared with lung tissue from 13 patients with constrictive bronchiolitis (CB) as positive controls and 10 normal autopsied control lungs. We semi-quantitatively analyzed SA structure, inflammation, architectural features and the bronchiolar epithelial immunohistochemical expression of TGF-beta, MMP-2, 7, 9, and their tissue inhibitors (TIMP-1, 2).
RESULTS: Compared to controls, patients with UIP, NSIP and CB presented increased bronchiolar inflammation, peribronchiolar inflammation and fibrosis and decreased luminal areas. UIP patients had thicker walls due to an increase in most airway compartments. NSIP patients presented increased epithelial areas, whereas patients with CB had larger inner wall areas. All of the groups studied presented increased bronchiolar expression of MMP-7 and MMP-9, compared to the controls.
CONCLUSION: We conclude that SAs are pathologically altered and may take part in the lung-remodeling process in idiopathic interstitial pneumonias. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19690403     DOI: 10.1159/000235722

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  6 in total

1.  Toll-like receptors 2, 3 and 4 and thymic stromal lymphopoietin expression in fatal asthma.

Authors:  D S Ferreira; R Annoni; L F F Silva; M Buttignol; A B G Santos; M C R Medeiros; L N S Andrade; C Y Yick; P J Sterk; J L M Sampaio; M Dolhnikoff; S E Wenzel; T Mauad
Journal:  Clin Exp Allergy       Date:  2012-10       Impact factor: 5.018

2.  Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.

Authors:  Ezra R Miller; Rachel K Putman; Alejandro A Diaz; Hanfei Xu; Raúl San José Estépar; Tetsuro Araki; Mizuki Nishino; Sergio Poli de Frías; Tomoyuki Hida; James Ross; Harvey Coxson; Josée Dupuis; George T O'Connor; Edwin K Silverman; Ivan O Rosas; Hiroto Hatabu; George Washko; Gary M Hunninghake
Journal:  Ann Am Thorac Soc       Date:  2019-04

3.  Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan.

Authors:  Matthew S King; Rosana Eisenberg; John H Newman; James J Tolle; Frank E Harrell; Hui Nian; Mathew Ninan; Eric S Lambright; James R Sheller; Joyce E Johnson; Robert F Miller
Journal:  N Engl J Med       Date:  2011-07-21       Impact factor: 91.245

4.  A sigmoidal fit for pressure-volume curves of idiopathic pulmonary fibrosis patients on mechanical ventilation: clinical implications.

Authors:  Juliana C Ferreira; Fabio E M Benseñor; Marcelo J J Rocha; Joao M Salge; R Scott Harris; Atul Malhotra; Ronaldo A Kairalla; Robert M Kacmarek; Carlos R R Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 5.  The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering MUC5B.

Authors:  Qinghua Zhang; Yan Wang; Danhua Qu; Jinyan Yu; Junling Yang
Journal:  Biomed Res Int       Date:  2019-06-11       Impact factor: 3.411

6.  The UIP/IPF fibroblastic focus is a collagen biosynthesis factory embedded in a distinct extracellular matrix.

Authors:  Jeremy A Herrera; Lewis Dingle; M Angeles Montero; Rajamiyer V Venkateswaran; John F Blaikley; Craig Lawless; Martin A Schwartz
Journal:  JCI Insight       Date:  2022-08-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.